Source: MarketScreener

Novelion Therapeutics: Novelion Therapeutics Provides Update on Liquidation and Claims Process

(marketscreener.com) VANCOUVER, British Columbia, June 12, 2020 -- Novelion Therapeutics Inc. by Alvarez & Marsal Canada Inc., Novelion's court appointed liquidator today provides an update on the Company's voluntary liquidation process that started on January 16, 2020 . Liquidation Update The Liquidator is currently...https://www.marketscreener.com/NOVELION-THERAPEUTICS-INC-32543639/news/Novelion-Therapeutics-Provides-Update-on-Liquidation-and-Claims-Process-30763601/?utm_medium=RSS&utm_content=20200612

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
100-250
Benjamin Harshbarger's photo - Interim-CEO of Novelion Therapeutics

Interim-CEO

Benjamin Harshbarger

CEO Approval Rating

83/100

Read more